返回 Agenda
Session 2 : Advancing Pharmacovigilance: regulatory use of database and Risk Management Plan
Session Chair(s)
Min-Jung Lim, MPharm, RPh
CEO & Senior Pharmacovigilance Consultant, MediSafe, Pharmacovigilance Services, Korea, Republic of
In-sook Park, PhD
Director , BRSLab, Korea, Republic of
Speaker(s)
Session 2 - 1
Takashi Waki, PhD, RPh
Epidemiologist, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Session 2 - 2
Bonggi Kim, PhD
Director, Korea Institute of Drug Safety and Risk Management, Korea, Republic of
Session 2 - 3
Jingyu (Julia) Luan, PhD
Executive Regulatory Science Director , AstraZeneca, United States
Ju-Young Shin, PhD
Professor, Seoul National University, Korea, Republic of
Hyungjin Jung, MD, MBA
Senior Medical Director, Lundbeck Korea, Korea, Republic of
Younglim Kim, PhD
Director General, National Institute of Food & Drug Safety (NIFDS), Korea, Republic of
Nam-Kyong Choi, PhD
Research Professor, Division of Clinical Epidemiology, Seoul National University College of Medicine/Seoul National University Hospital, Korea, Republic of